Acute Lymphoblastic Leukemia

Overview

Acute lymphoblastic leukemia, often called ALL, is a type of blood cancer that starts in the bone marrow, the soft tissue inside bones where blood cells are made. In ALL, the body produces too many immature white blood cells called lymphoblasts. These abnormal cells do not work properly and can crowd out healthy blood cells.

ALL develops quickly and needs prompt medical assessment and treatment. It can affect both children and adults, although it is more common in children. Many people with ALL are treated by a multidisciplinary oncology team, which may include hematologists, medical oncologists, pediatric oncologists, specialized nurses, laboratory experts, and supportive care professionals.

Because symptoms can resemble those of common infections or other conditions, diagnosis requires medical tests. Early evaluation helps doctors understand the type of leukemia, how it is affecting the body, and which treatment approach may be most appropriate.

Symptoms

The symptoms of acute lymphoblastic leukemia are often related to a shortage of normal blood cells or the buildup of leukemia cells in the body. Symptoms may appear over days or weeks and can vary from person to person.

• Persistent tiredness, weakness, or low energy
• Pale skin or shortness of breath during usual activities
• Frequent infections or infections that are slow to improve
• Fever without a clear cause
• Easy bruising, nosebleeds, bleeding gums, or tiny red spots on the skin
• Bone or joint pain
• Swollen lymph nodes in the neck, underarm, or groin
• Abdominal swelling or discomfort due to enlargement of organs such as the liver or spleen
• Loss of appetite or unintentional weight loss
• Headache, vomiting, vision changes, or balance problems if the central nervous system is involved

These symptoms do not always mean leukemia is present, but they should be assessed by a healthcare professional, especially if they are persistent, worsening, or unexplained.

Causes and Risk Factors

In most cases, the exact cause of acute lymphoblastic leukemia is not known. ALL occurs when changes develop in the DNA of immature blood-forming cells. These changes cause the cells to grow and multiply abnormally instead of maturing into healthy blood cells.

Several factors may increase the risk of developing ALL, although many people with ALL have no known risk factors. Possible risk factors include certain inherited genetic conditions, previous exposure to high levels of radiation, and previous treatment with some forms of cancer therapy. A weakened immune system or certain rare medical conditions may also be associated with increased risk.

ALL is not usually considered a disease that can be prevented through lifestyle changes. It is also not contagious and cannot be passed from one person to another through normal contact.

Diagnosis

Diagnosis begins with a medical history, physical examination, and blood tests. A complete blood count may show abnormal numbers of white blood cells, red blood cells, or platelets. A blood smear may help identify immature or abnormal cells.

If leukemia is suspected, doctors usually recommend a bone marrow examination. This test allows specialists to examine cells from the bone marrow under a microscope and perform additional laboratory studies. These studies help confirm the diagnosis and identify the specific subtype of ALL.

Further tests may include genetic and molecular analysis of leukemia cells. These results can help guide treatment planning. Imaging tests may be used to evaluate symptoms or check whether certain organs are affected. A sample of fluid from around the brain and spinal cord may also be examined to assess whether leukemia cells are present in the central nervous system.

The diagnostic process helps doctors understand the biology of the disease and the patient’s overall health, both of which are important when planning care.

Treatment Options

Treatment for acute lymphoblastic leukemia is usually started soon after diagnosis. The treatment plan depends on factors such as age, overall health, ALL subtype, genetic features of the leukemia cells, and whether the central nervous system is involved.

Chemotherapy is a central part of treatment for most patients. It is typically given in phases over a period of time, with the goal of reducing leukemia cells and helping the bone marrow recover healthy blood production. Treatment may include therapy directed at the central nervous system to reduce the risk of leukemia cells being present there.

Some patients may receive targeted therapy if specific changes are found in the leukemia cells. Immunotherapy may be considered in certain situations, using the immune system to help recognize and attack leukemia cells. Stem cell transplantation may be discussed for selected patients, depending on disease features and response to treatment.

Supportive care is also very important. This may include blood product support, infection prevention and treatment, nutritional support, management of side effects, and psychological support for patients and families. Because treatment can be intensive, close monitoring by an experienced oncology team is essential.

When to See a Doctor

Seek medical advice if you or your child has persistent or unexplained symptoms such as ongoing fatigue, frequent infections, fever, easy bruising or bleeding, bone pain, swollen lymph nodes, or unexplained weight loss. These symptoms can have many causes, but they should not be ignored.

Urgent medical attention is needed for heavy bleeding, severe shortness of breath, confusion, severe headache with vomiting, sudden weakness, high fever, or signs of a serious infection. Patients already diagnosed with ALL should contact their care team promptly if new or worsening symptoms occur during or after treatment.

Acute lymphoblastic leukemia is a serious condition, but specialized care can provide accurate diagnosis, structured treatment planning, and supportive care throughout the treatment journey.